28214898|t|Early Development of Parvalbumin -, Somatostatin -, and Cholecystokinin -Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency
28214898|a|Prenatal maternal infection and maternal iron deficiency during pregnancy are 2 early environmental insults associated with increased risk for schizophrenia in offspring. Substantial evidence suggests that abnormalities in inhibitory γ-aminobutyric acid (GABA) interneuron function, especially in the parvalbumin subtype of GABA interneuron, both developmentally and in adulthood, may contribute mechanistically to cognitive deficits and psychotic symptoms in schizophrenia. This study used a rat model to test whether prenatal immune activation with lipopolysaccharide (LPS; at gestation days, GD, 15 and 16) or maternal iron deficiency (from GD 2 to postnatal day P7) or the combination of both insults alters major subtypes of GABAergic interneurons (parvalbumin, somatostatin, cholecystokinin) in brain regions relevant to schizophrenia (medial and dorsolateral prefrontal cortex [PFC], hippocampal CA1 and dentate gyrus, ventral subiculum) in offspring at P14 or P28. Prenatal LPS treatment significantly increased the density of parvalbumin - immunoreactive neurons at P14 in the medial PFC, dorsolateral PFC, and ventral subiculum of offspring born from iron-sufficient but not iron-deficient dams. Prenatal LPS also increased cholecystokinin neuron density in the medial PFC at P28, under both iron-sufficient and iron-deficient conditions. We observed a large increase in parvalbumin neuron density from P14 to P28 in the medial PFC and subiculum across all birth groups, that was not observed in other brain regions, and significant decreases in somatostatin neuron density from P14 to P28 in all brain regions examined across all birth groups, indicating differential developmental trajectories for parvalbumin and somatostatin neurons in various brain regions during this early postnatal period. Thus, it appears that the medial PFC and ventral subiculum, brain regions involved in circuitry modulating ventral tegmental dopamine and nucleus accumbens activities, may be regions vulnerable to effects of prenatal LPS on specific subpopulations of interneurons. It is known that the timing of maturation and expansion of parvalbumin neurons in early development provides threshold levels of inhibition that trigger critical periods for cortical plasticity, leading to long-term circuit consolidation. Thus, our finding of increased parvalbumin neuron density at early developmental times might suggest a mechanism by which an acute prenatal insult like LPS exposure could produce long-term changes in prefrontal cortical or subicular function.
28214898	0	17	Early Development	T033	C1856550
28214898	21	32	Parvalbumin	T116,T123	C0030616
28214898	36	48	Somatostatin	T116,T121,T125	C0037659
28214898	56	71	Cholecystokinin	T116,T121,T125	C0008328
28214898	84	91	Neurons	T025	C0027882
28214898	95	104	Rat Brain	T023	C1882598
28214898	115	123	Prenatal	T079	C2828394
28214898	124	141	Immune Activation	T043	C1155000
28214898	146	170	Maternal Iron Deficiency	T047	C0240066
28214898	171	179	Prenatal	T079	C2828394
28214898	180	198	maternal infection	T033	C0239997
28214898	203	227	maternal iron deficiency	T047	C0240066
28214898	235	244	pregnancy	T040	C0032961
28214898	279	294	associated with	T080	C0332281
28214898	295	304	increased	T081	C0205217
28214898	305	309	risk	T078	C0035647
28214898	314	327	schizophrenia	T048	C0036341
28214898	331	340	offspring	T099	C0680063
28214898	342	362	Substantial evidence	T078	C3887511
28214898	377	390	abnormalities	T033	C1867987
28214898	394	443	inhibitory γ-aminobutyric acid (GABA) interneuron	T025	C0682694
28214898	405	424	γ-aminobutyric acid	T116,T123	C0016904
28214898	426	430	GABA	T116,T123	C0016904
28214898	444	452	function	T043	C0007613
28214898	472	483	parvalbumin	T116,T123	C0030616
28214898	484	491	subtype	T185	C0449560
28214898	495	511	GABA interneuron	T025	C0815002
28214898	538	550	in adulthood	T079	C2945655
28214898	586	604	cognitive deficits	T048	C0009241
28214898	609	627	psychotic symptoms	T184	C0871189
28214898	631	644	schizophrenia	T048	C0036341
28214898	664	667	rat	T015	C0034693
28214898	668	673	model	T050	C0012644
28214898	690	698	prenatal	T079	C2828394
28214898	699	716	immune activation	T043	C1155000
28214898	722	740	lipopolysaccharide	T109	C0023810
28214898	742	745	LPS	T109	C0023810
28214898	750	759	gestation	T040	C0032961
28214898	760	764	days	T079	C0439228
28214898	766	768	GD	T079	C0439228
28214898	784	808	maternal iron deficiency	T047	C0240066
28214898	815	817	GD	T079	C0439228
28214898	823	836	postnatal day	T079	C0439228
28214898	889	897	subtypes	T185	C0449560
28214898	901	923	GABAergic interneurons	T025	C0815002
28214898	925	936	parvalbumin	T116,T123	C0030616
28214898	938	950	somatostatin	T116,T121,T125	C0037659
28214898	952	967	cholecystokinin	T116,T121,T125	C0008328
28214898	972	985	brain regions	T029	C1273723
28214898	998	1011	schizophrenia	T048	C0036341
28214898	1013	1019	medial	T023	C0162783
28214898	1024	1054	dorsolateral prefrontal cortex	T023	C4019080
28214898	1056	1059	PFC	T023	C0162783
28214898	1062	1077	hippocampal CA1	T029	C0694598
28214898	1082	1095	dentate gyrus	T023	C0152314
28214898	1097	1114	ventral subiculum	T023	C3499061
28214898	1119	1128	offspring	T099	C0680063
28214898	1144	1152	Prenatal	T079	C2828394
28214898	1153	1156	LPS	T109	C0023810
28214898	1157	1166	treatment	T061	C0087111
28214898	1181	1190	increased	T081	C0205217
28214898	1195	1202	density	T081	C0178587
28214898	1206	1217	parvalbumin	T116,T123	C0030616
28214898	1220	1242	immunoreactive neurons	T025	C0027882
28214898	1257	1263	medial	T082	C0205098
28214898	1264	1267	PFC	T023	C0162783
28214898	1269	1285	dorsolateral PFC	T023	C4019080
28214898	1291	1308	ventral subiculum	T023	C3499061
28214898	1312	1321	offspring	T099	C0680063
28214898	1322	1326	born	T040	C0005615
28214898	1332	1347	iron-sufficient	T033	C0243095
28214898	1356	1375	iron-deficient dams	T033	C0243095
28214898	1377	1385	Prenatal	T079	C2828394
28214898	1386	1389	LPS	T109	C0023810
28214898	1395	1404	increased	T081	C0205217
28214898	1405	1420	cholecystokinin	T116,T121,T125	C0008328
28214898	1421	1427	neuron	T025	C0027882
28214898	1428	1435	density	T081	C0178587
28214898	1443	1449	medial	T082	C0205098
28214898	1450	1453	PFC	T023	C0162783
28214898	1473	1488	iron-sufficient	T033	C0243095
28214898	1493	1518	iron-deficient conditions	T033	C0243095
28214898	1540	1548	increase	T169	C0442805
28214898	1552	1563	parvalbumin	T116,T123	C0030616
28214898	1564	1570	neuron	T025	C0027882
28214898	1571	1578	density	T081	C0178587
28214898	1602	1608	medial	T082	C0205098
28214898	1609	1612	PFC	T023	C0162783
28214898	1617	1626	subiculum	T023	C3499061
28214898	1638	1650	birth groups	T078	C0441833
28214898	1683	1696	brain regions	T029	C1273723
28214898	1714	1723	decreases	T081	C0547047
28214898	1727	1739	somatostatin	T116,T121,T125	C0037659
28214898	1740	1746	neuron	T025	C0027882
28214898	1747	1754	density	T081	C0178587
28214898	1778	1791	brain regions	T029	C1273723
28214898	1812	1824	birth groups	T078	C0441833
28214898	1837	1876	differential developmental trajectories	T080	C0205556
28214898	1881	1892	parvalbumin	T116,T123	C0030616
28214898	1897	1909	somatostatin	T116,T121,T125	C0037659
28214898	1910	1917	neurons	T025	C0027882
28214898	1929	1942	brain regions	T029	C1273723
28214898	1955	1977	early postnatal period	T079	C0871109
28214898	2005	2011	medial	T082	C0205098
28214898	2012	2015	PFC	T023	C0162783
28214898	2020	2037	ventral subiculum	T023	C3499061
28214898	2039	2052	brain regions	T029	C1273723
28214898	2065	2085	circuitry modulating	T042	C1254358
28214898	2086	2112	ventral tegmental dopamine	T023	C1183185
28214898	2117	2134	nucleus accumbens	T023	C0028633
28214898	2135	2145	activities	T052	C0441655
28214898	2154	2161	regions	T029	C1273723
28214898	2176	2183	effects	T080	C1280500
28214898	2187	2195	prenatal	T079	C2828394
28214898	2196	2199	LPS	T109	C0023810
28214898	2212	2226	subpopulations	T185	C0008902
28214898	2230	2242	interneurons	T025	C0021792
28214898	2275	2285	maturation	T043	C1623343
28214898	2290	2299	expansion	T043	C0007595
28214898	2303	2314	parvalbumin	T116,T123	C0030616
28214898	2315	2322	neurons	T025	C0027882
28214898	2326	2343	early development	T033	C1856550
28214898	2353	2362	threshold	T080	C0449864
28214898	2363	2369	levels	T080	C0441889
28214898	2373	2383	inhibition	T042	C0027790
28214898	2397	2413	critical periods	T079	C0010339
28214898	2418	2437	cortical plasticity	T042	C0027880
28214898	2450	2481	long-term circuit consolidation	T041	C0679057
28214898	2504	2513	increased	T081	C0205217
28214898	2514	2525	parvalbumin	T116,T123	C0030616
28214898	2526	2532	neuron	T025	C0027882
28214898	2533	2540	density	T081	C0178587
28214898	2544	2569	early developmental times	T079	C0040223
28214898	2586	2595	mechanism	T169	C0441712
28214898	2608	2629	acute prenatal insult	T037	C0178314
28214898	2635	2638	LPS	T109	C0023810
28214898	2639	2647	exposure	T080	C0332157
28214898	2662	2671	long-term	T079	C0443252
28214898	2672	2679	changes	T169	C0392747
28214898	2683	2724	prefrontal cortical or subicular function	T042	C1254358